Organogenesis (ORGO)
(Delayed Data from NSDQ)
$2.90 USD
+0.04 (1.40%)
Updated Apr 19, 2024 03:59 PM ET
After-Market: $2.91 +0.01 (0.34%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 41% (147 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.52 | 9.99 |
Current Quarter Estimate | -0.03 | -2.04 | 60.00 |
Year Ago Quarter Estimate | -0.02 | -0.59 | 52.54 |
Next Quarter Estimate | NA | -2.00 | 61.00 |
Next Year Estimate | NA | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -125.00 | 10.20 | 17.08 |
Next Year | NA | 13.80 | 8.00 |
Last 5 Years | NA | 5.90 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 72.50 | -5.88 |
Price/Book (MRQ) | 1.37 | 1.87 |
Price/Cash Flow (MRFY) | 13.49 | 9.05 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 1.14% | -19.76% |
Return on Equity (TTM) | 1.81% | -72.91% |
Debt to Equity (MRQ) | NA | 0.30 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.